PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
NuGyn, Inc

Press Release


Receive press releases from NuGyn, Inc: By Email RSS Feeds:

NuGyn, Inc. Announces New Strategic Partner for Eros Therapy®: Davis-Lobdell Instruments, Inc.


Davis-Lobdell Instruments to Sell and Distribute Eros-Therapy Throughout the Midwestern United States

Minneapolis, MN, May 25, 2012 --(PR.com)-- NuGyn, Inc., makers of Eros Therapy®, the only FDA-cleared medical device for the treatment of female sexual arousal disorder (FSAD), announced a new sales and distribution partnership with Davis-Lobdell Instruments, Inc. today.

NuGyn CEO Claire Hovland stated, “We are extremely pleased to announce that Davis-Lobdell Instruments has become our most recent strategic partner. This will enable more physicians and patients across the Midwest to access Eros Therapy, and help ensure that appropriate patients know there is something they can do to rediscover control over their sexual response.”

“This partnership offers our customers, physician clinics and offices, an opportunity to differentiate their services and to offer their patients a valuable non-pharmacologic tool to improve female sexual response. We look forward to providing education and distribution services for Eros Therapy,” added Davis-Lobdell Account Representative Steve Davis.

This partnership, effective immediately, allows NuGyn, Inc. to fully support the rising demand for Eros Therapy in the Midwest.

About NuGyn, Inc. and Eros Therapy
NuGyn, Inc. is a provider of innovative medical products that fill unmet needs in women's healthcare. NuGyn markets Eros Therapy, a medical device that was cleared by the FDA, through a 510(k) process, to treat Female Sexual Arousal Disorder (FSAD) in April 2000.

Eros Therapy is a small, hand-held device used to improve blood flow to the clitoris and genitalia and gently recondition vaginal tissues. With therapeutic use for several months, sexual function is restored to a significant number of women. In one clinical trial,[1] 90% of women with FSAD reported an increase in sensation and 80% reported increased sexual satisfaction. The Eros device is currently available in the United States, Canada, Europe, and Australia. For more information, visit www.eros-therapy.com.

About Davis-Lobdell Instruments, Inc.

Davis-Lobdell Instruments is a provider of quality medical devices, including surgical and diagnostic instruments. With over 40 years of experience, Davis-Lobdell partners with medical device manufacturers to provide products to physicians and patients that support high quality patient care. For more information, visit www.davis-lobdell.com.

[1] Billups, K. L., et al. A new non-pharmacological vacuum therapy for female sexual dysfunction. Journal of Sex & Marital Therapy. 27(5):435-441, 2001.
Contact Information
NuGyn, Inc
Erika Hovland
215-668-7870
Contact
www.eros-therapy.com

Click here to view the list of recent Press Releases from NuGyn, Inc
Promote Your Business